Legal & General Group Plc - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 100 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$4,543
-24.0%
5,0660.0%0.00%
Q4 2022$5,978
-84.3%
5,0660.0%0.00%
Q3 2022$38,000
+40.7%
5,066
+17.1%
0.00%
Q2 2022$27,000
+22.7%
4,327
+62.0%
0.00%
Q1 2022$22,000
+57.1%
2,6710.0%0.00%
Q4 2021$14,000
-22.2%
2,6710.0%0.00%
Q3 2021$18,000
-21.7%
2,6710.0%0.00%
Q2 2021$23,000
-25.8%
2,671
-24.3%
0.00%
Q1 2021$31,000
-31.1%
3,528
-3.8%
0.00%
Q4 2020$45,000
+66.7%
3,669
+10.4%
0.00%
Q3 2020$27,000
-28.9%
3,322
-16.1%
0.00%
Q2 2020$38,000
+40.7%
3,959
-0.9%
0.00%
Q1 2020$27,000
-62.5%
3,993
-17.2%
0.00%
Q4 2019$72,000
+80.0%
4,822
+23.3%
0.00%
Q3 2019$40,000
-2.4%
3,9120.0%0.00%
Q2 2019$41,000
+310.0%
3,912
+327.5%
0.00%
Q1 2017$10,0000.0%9150.0%0.00%
Q4 2016$10,0009150.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$20,462,0006.02%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$18,315,0003.89%
NEXTHERA CAPITAL LP 263,600$3,018,0001.54%
SPHERA FUNDS MANAGEMENT LTD. 385,301$4,412,0000.86%
RA Capital Management 354,200$4,056,0000.50%
DAFNA Capital Management LLC 35,977$412,0000.35%
Boxer Capital, LLC 138,331$1,584,0000.35%
SABBY MANAGEMENT, LLC 238,907$2,735,0000.15%
Monashee Investment Management LLC 31,500$361,0000.14%
Lombard Odier Asset Management (USA) Corp 100,000$1,145,0000.11%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders